Medicine & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Addenbrookes Hospital, Cambridge
Ovarian cancer patients prefer having CA125 results available at follow-up
June 2nd, 2006
The availability of CA125 results when patients with epithelial ovarian cancer come in for routine follow-up improves patient education. A recent study in England was conducted "to evaluate the use of CA125 in the follow-up of women with epithelial ovarian cancer in the Cambridge Gynaecologic Oncology Centre" and "to institute changes depending on patients' preferences." C. Palmer and colleagues, Addenbrookes Hospital, explained, "A patient questionnaire was developed on follow-up, CA125 estimation and patient education in epithelial ovarian cancer and CA125. Initially, 100 patients were evaluated, and a change in practice was instituted. This was...
Source: Medicine & Law Weekly (2006-06-02)
|
